432 related articles for article (PubMed ID: 18068449)
21. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH).
Spaliviero M; Araki M; Page JB; Wong C
Lasers Surg Med; 2008 Oct; 40(8):529-34. PubMed ID: 18798292
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of 80 W KTP laser vaporization of the large prostate.
Tugcu V; Tasci AI; Sahin S; Ordekci Y; Karakas OF; Zorluoglu F
Urol Int; 2007; 79(4):316-20. PubMed ID: 18025849
[TBL] [Abstract][Full Text] [Related]
23. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
24. High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia.
Araki M; Lam PN; Wong C
J Endourol; 2008 Jun; 22(6):1311-4. PubMed ID: 18484893
[TBL] [Abstract][Full Text] [Related]
25. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial.
Elmansy HM; Elzayat E; Elhilali MM
J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828
[TBL] [Abstract][Full Text] [Related]
26. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
Issa MM; Runken MC; Grogg AL; Shah MB
Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
[TBL] [Abstract][Full Text] [Related]
27. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
28. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
Kumar SM
J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
[TBL] [Abstract][Full Text] [Related]
29. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
[TBL] [Abstract][Full Text] [Related]
30. GreenLight 180W XPS photovaporization of the prostate: how I do it.
Zorn KC; Liberman D
Can J Urol; 2011 Oct; 18(5):5918-26. PubMed ID: 22018158
[TBL] [Abstract][Full Text] [Related]
31. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.
Naspro R; Bachmann A; Gilling P; Kuntz R; Madersbacher S; Montorsi F; Reich O; Stief C; Vavassori I
Eur Urol; 2009 Jun; 55(6):1345-57. PubMed ID: 19361906
[TBL] [Abstract][Full Text] [Related]
32. Photoselective prostatic vaporization for bladder outlet obstruction: 12-month evaluation of storage and voiding symptoms.
De Nunzio C; Miano R; Trucchi A; Miano L; Franco G; Squillacciotti S; Tubaro A
J Urol; 2010 Mar; 183(3):1098-103. PubMed ID: 20092849
[TBL] [Abstract][Full Text] [Related]
33. [Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan].
Kuromatsu I; Imamura T; Sugimura Y
Nihon Hinyokika Gakkai Zasshi; 2006 Nov; 97(7):815-22. PubMed ID: 17154023
[TBL] [Abstract][Full Text] [Related]
34. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
[TBL] [Abstract][Full Text] [Related]
35. High-power (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients.
Yuan J; Wang H; Wu G; Liu H; Zhang Y; Yang L
Postgrad Med J; 2008 Jan; 84(987):46-9. PubMed ID: 18230751
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia.
Fu WJ; Hong BF; Wang XX; Yang Y; Cai W; Gao JP; Chen YF; Zhang CE
Asian J Androl; 2006 May; 8(3):367-71. PubMed ID: 16625289
[TBL] [Abstract][Full Text] [Related]
37. Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate.
Heinrich E; Schiefelbein F; Schoen G
Eur Urol; 2007 Dec; 52(6):1632-7. PubMed ID: 17689002
[TBL] [Abstract][Full Text] [Related]
38. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital.
Malde S; Rajagopalan A; Patel N; Simoes A; Choi W; Shrotri N
J Endourol; 2012 Jul; 26(7):878-83. PubMed ID: 22260554
[TBL] [Abstract][Full Text] [Related]
39. The effects of 5α-reductase inhibition on benign prostatic hyperplasia treated by photoselective vaporization prostatectomy with the 120 Watt GreenLight HPS laser system.
Strom KH; Gu X; Spaliviero M; Wong C
J Am Coll Surg; 2011 Feb; 212(2):244-50. PubMed ID: 21183365
[TBL] [Abstract][Full Text] [Related]
40. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
Goh AC; Gonzalez RR
J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
